Wouter Nagengast
Appearances
- DateMay 9, 2023Current guidelines advise esophagectomy for submucosal esophageal adenocarcinoma (T1b EAC). However, data from retrospective studies suggest that endoscopic follow-up (FU) may be a valid alternative in patients without signs of lymph node metastases (LNM) at baseline…
Presenter
Speakers
Westmead hospital, University of SydneyUniversitatsklinikum Augsburg - DateMay 9, 2023Current guidelines advise esophagectomy for submucosal esophageal adenocarcinoma (T1b EAC). However, data from retrospective studies suggest that endoscopic follow-up (FU) may be a valid alternative in patients without signs of lymph node metastases (LNM) at baseline…
Presenter
Speakers
- DateMay 9, 2023For training deep learning algorithms in medical imaging, application-specific data is often scarce…
Speakers
Presenter
- DateMay 8, 2023BACKGROUND: Using EsoCheck (EC), a non-endoscopic balloon device for sampling the distal esophagus, coupled with EsoGuard (EG), a DNA based testing screening for Barrett’s esophagus (BE), we have previously reported high sensitivity and specificity for detection of BE among patients with known BE c…
Speakers
Presenter
- DateMay 8, 2023BACKGROUND: Using EsoCheck (EC), a non-endoscopic balloon device for sampling the distal esophagus, coupled with EsoGuard (EG), a DNA based testing screening for Barrett’s esophagus (BE), we have previously reported high sensitivity and specificity for detection of BE among patients with known BE c…
- DateMay 9, 2023BACKGROUND: Biological treatment in inflammatory bowel disease (IBD) patients is currently hampered by high non-response rates. To enhance personalized medicine and predict response to biological therapeutics such as vedolizumab, the working mechanism should be elucidated…
- DateMay 18, 2024Endoscopic full thickness resection (eFTR) is increasingly used as a minimally invasive diagnostic and potential therapeutic approach for smaller (≤2cm) T1 colorectal cancer (CRC)…
Presenter
Speakers
- DateMay 21, 2024Optimal management following radical endoscopic resection (R0 ER) of T1 esophageal adenocarcinoma (EAC) is still a matter of debate due to conflicting reports on the risk for lymph node metastases (LNM). In case of histological risk factors for LNM, i.e…
Presenter
Speakers
Westmead hospital, University of SydneyCleveland Clinic London - DateMay 21, 2024Barrett’s esophagus (BE) with early neoplasia is an indication for endoscopic treatment. Patients with non-dysplastic BE are typically enrolled in an endoscopic surveillance program to enable early detection, and treatment, of BE related neoplasia…
- DateMay 21, 2024The neoplastic progression risk in Barrett’s Esophagus (BE) increases with increasing BE length. Therefore, some guidelines recommend that patients with ultra long-segment BE ≥10cm (ULS-BE) are referred to an expert center, however, recommendations on further management are lacking…
